HUP0001501A2 - Paracetamol tartalmú tabletta - Google Patents

Paracetamol tartalmú tabletta

Info

Publication number
HUP0001501A2
HUP0001501A2 HU0001501A HUP0001501A HUP0001501A2 HU P0001501 A2 HUP0001501 A2 HU P0001501A2 HU 0001501 A HU0001501 A HU 0001501A HU P0001501 A HUP0001501 A HU P0001501A HU P0001501 A2 HUP0001501 A2 HU P0001501A2
Authority
HU
Hungary
Prior art keywords
tablet
paracetamol
swallowed
boiled
excipient
Prior art date
Application number
HU0001501A
Other languages
English (en)
Inventor
Timothy James Grattan
Original Assignee
Smithkline Beecham P.L.C.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham P.L.C. filed Critical Smithkline Beecham P.L.C.
Publication of HUP0001501A2 publication Critical patent/HUP0001501A2/hu
Publication of HUP0001501A3 publication Critical patent/HUP0001501A3/hu
Publication of HU224983B1 publication Critical patent/HU224983B1/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Detergent Compositions (AREA)

Abstract

A találmány tárgyát lenyelhető tabletta- vagy kapszűlakészítményképezi, amely paracetamőlt, nátriűm-hidrőgén-karbőnátőt és legalábbegy gyógyászati szempőntból elfőgadható segédanyagőt tartalmaz. ŕ
HU0001501A 1997-03-05 1998-02-27 Swallow tablet comprising paracetamol HU224983B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9704524.9A GB9704524D0 (en) 1997-03-05 1997-03-05 Composition
PCT/EP1998/001284 WO1998038983A2 (en) 1997-03-05 1998-02-27 Swallow tablet comprising paracetamol

Publications (3)

Publication Number Publication Date
HUP0001501A2 true HUP0001501A2 (hu) 2000-09-28
HUP0001501A3 HUP0001501A3 (en) 2001-01-29
HU224983B1 HU224983B1 (en) 2006-05-29

Family

ID=10808717

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0001501A HU224983B1 (en) 1997-03-05 1998-02-27 Swallow tablet comprising paracetamol

Country Status (36)

Country Link
US (1) US6316025B1 (hu)
EP (1) EP0981334B1 (hu)
JP (1) JP2001513801A (hu)
KR (1) KR100465895B1 (hu)
CN (1) CN100389751C (hu)
AP (1) AP1084A (hu)
AR (1) AR011919A1 (hu)
AT (1) ATE240720T1 (hu)
AU (1) AU721851B2 (hu)
BG (1) BG64348B1 (hu)
BR (1) BR9807992A (hu)
CA (1) CA2283408C (hu)
CO (1) CO4940406A1 (hu)
CY (1) CY2367B1 (hu)
CZ (1) CZ294078B6 (hu)
DE (1) DE69814850T2 (hu)
DK (1) DK0981334T3 (hu)
EA (1) EA001918B1 (hu)
ES (1) ES2199435T3 (hu)
GB (1) GB9704524D0 (hu)
HK (1) HK1027026A1 (hu)
HU (1) HU224983B1 (hu)
ID (1) ID22233A (hu)
IL (1) IL131552A (hu)
MY (1) MY119722A (hu)
NO (1) NO327456B1 (hu)
NZ (1) NZ337418A (hu)
PE (1) PE68899A1 (hu)
PL (1) PL190988B1 (hu)
PT (1) PT981334E (hu)
SK (1) SK282277B6 (hu)
TR (1) TR199902175T2 (hu)
TW (1) TW508242B (hu)
UA (1) UA59388C2 (hu)
WO (1) WO1998038983A2 (hu)
ZA (1) ZA981832B (hu)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6211246B1 (en) 1999-06-10 2001-04-03 Mcneil-Ppc, Inc. Rapidly absorbed liquid compositions
NZ508291A (en) * 1999-11-24 2002-09-27 Mcneil Ppc Inc Use of acetaminophen in a medicament for treating migraine symptoms
GB0006897D0 (en) * 2000-03-23 2000-05-10 Smithkline Beecham Plc Medicaments
GB0114069D0 (en) * 2001-06-08 2001-08-01 Smithkline Beecham Plc Composition
GB0129117D0 (en) * 2001-12-05 2002-01-23 Glaxo Group Ltd Pharmaceutical composition
JP2006522790A (ja) * 2003-04-11 2006-10-05 ファイザー・インク エレトリプタンと重炭酸ナトリウムを含む医薬組み合わせ物
US8216610B2 (en) * 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
ES2624585T3 (es) * 2004-05-28 2017-07-17 Imaginot Pty Ltd. Sistema de suministro de compuesto terapéutico oral
AU2005247047C1 (en) * 2004-05-28 2010-03-11 Glaxo Group Limited Oral delivery system
DE102004042139B4 (de) * 2004-08-31 2009-06-10 Aristocon Verwaltungs- Gmbh Perorale Darreichungsformen zur Erzielung eines Retardierungseffektes nach der Arzneimitteleinnahme mit einer Mahlzeit
PT1807068E (pt) * 2004-10-28 2010-04-19 Novartis Ag Composição que inclui acetaminofeno, cafeína e opcionalmente aspirina em conjunto com um agente alcalino de forma a realçar a absorção
US9060950B2 (en) * 2005-06-13 2015-06-23 Paul H. Rosenberg, Proximate Concepts, LLC. Emetic embedded capsule
WO2006138278A1 (en) * 2005-06-13 2006-12-28 Paul Rosenberg Emetic embedded capsule
KR100702069B1 (ko) * 2005-10-31 2007-03-30 (주)이엘티사이언스 파라세타몰 경구용 수용산제 복합조성물 및 그 제조방법
AU2006317530B2 (en) 2005-11-28 2011-09-01 Imaginot Pty Ltd Oral therapeutic compound delivery system
GB0607085D0 (en) * 2006-04-07 2006-05-17 Smithkline Beecham Corp Novel compositions
WO2008008120A1 (en) * 2006-07-14 2008-01-17 Fmc Corporation Solid form
US20080311162A1 (en) * 2007-05-16 2008-12-18 Olivia Darmuzey Solid form
US20110098359A1 (en) * 2007-08-07 2011-04-28 Stellenbosch University Compositions and Methods for Treatment of Glaucoma
KR101687580B1 (ko) 2016-07-19 2016-12-20 주식회사 씨.월드 의자 등받이부와 프레임부 조립구조
JP7472116B2 (ja) 2018-11-19 2024-04-22 ジャズ ファーマシューティカルズ アイルランド リミテッド 耐アルコール性製剤

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1182049A (en) * 1981-07-13 1985-02-05 Francis J. Sterbenz Apap antacid composition
EP0377906B1 (en) * 1989-01-12 1993-12-15 Bayer Ag Effervescent analgesic antacid composition having reduced sodium content
US4942039A (en) * 1989-05-09 1990-07-17 Miles Inc. Effervescent analgesic antacid composition having reduced sodium content
US5348745A (en) * 1989-05-09 1994-09-20 Miles Inc. Aqueous granulation solution and a method of tablet granulation
CA2021548A1 (en) * 1989-09-01 1991-03-02 Ronald Nash Duvall Effervescent cold or sinus allergy medicine composition having reduced sodium content
DE19502789A1 (de) 1995-01-28 1996-08-01 Dirk Krischenowski Arzneimittel

Also Published As

Publication number Publication date
SK119799A3 (en) 2000-02-14
GB9704524D0 (en) 1997-04-23
AR011919A1 (es) 2000-09-13
DE69814850T2 (de) 2004-03-11
BG103714A (en) 2000-05-31
EP0981334B1 (en) 2003-05-21
CN1253497A (zh) 2000-05-17
UA59388C2 (uk) 2003-09-15
CA2283408A1 (en) 1998-09-11
KR20000075897A (ko) 2000-12-26
CN100389751C (zh) 2008-05-28
ATE240720T1 (de) 2003-06-15
AU6828298A (en) 1998-09-22
ID22233A (id) 1999-09-23
JP2001513801A (ja) 2001-09-04
DE69814850D1 (de) 2003-06-26
MY119722A (en) 2005-07-29
PL190988B1 (pl) 2006-02-28
TR199902175T2 (xx) 1999-12-21
IL131552A (en) 2004-08-31
CZ314899A3 (cs) 2000-03-15
US6316025B1 (en) 2001-11-13
HK1027026A1 (en) 2001-01-05
EA199900709A1 (ru) 2000-08-28
CY2367B1 (en) 2004-06-04
AU721851B2 (en) 2000-07-13
BG64348B1 (bg) 2004-11-30
PL335502A1 (en) 2000-04-25
ZA981832B (en) 1998-12-11
HUP0001501A3 (en) 2001-01-29
HU224983B1 (en) 2006-05-29
EA001918B1 (ru) 2001-10-22
WO1998038983A2 (en) 1998-09-11
SK282277B6 (sk) 2002-01-07
BR9807992A (pt) 2000-03-08
AP1084A (en) 2002-07-23
CZ294078B6 (cs) 2004-09-15
PT981334E (pt) 2003-10-31
AP9901638A0 (en) 1999-09-30
NO994294D0 (no) 1999-09-03
KR100465895B1 (ko) 2005-01-13
CA2283408C (en) 2007-01-02
EP0981334A1 (en) 2000-03-01
ES2199435T3 (es) 2004-02-16
NZ337418A (en) 2000-05-26
NO327456B1 (no) 2009-07-06
DK0981334T3 (da) 2003-09-22
TW508242B (en) 2002-11-01
IL131552A0 (en) 2001-01-28
NO994294L (no) 1999-09-03
PE68899A1 (es) 1999-09-26
WO1998038983A3 (en) 1998-12-17
CO4940406A1 (es) 2000-07-24

Similar Documents

Publication Publication Date Title
HUP0001501A2 (hu) Paracetamol tartalmú tabletta
HUP0002196A2 (hu) Gyógyhatású táplálékkiegészítő cukorbetegek részére
DE50008336D1 (de) Mehrschichttablette zur verabreichung einer fixen kombination von tramadol und diclofenac
BR9912979B1 (pt) composição farmacêutica administrável oralmente, tablete de mascar, cápsula e uso de chitosan.
HUP0401978A2 (hu) Tamszulozintabletták
CY1107675T1 (el) Φαρμακευτικα αλατα τραμαδολης
EA200500909A1 (ru) Модифицированное высвобождение фармацевтической композиции
HUP0402293A2 (hu) Fexofenadint tartalmazó szájban diszpergálódó tablettakészítmény, bevonatos granulátum és eljárás az előállítására
HUP9904031A2 (hu) Nátrium-kloridot tartalmazó inzulinkészítmények
HUP0204109A2 (en) Oral preparations for diabetes
HUP9701111A2 (hu) Töltőanyag lágy zselatin kapszula gyógyszeradagolási formához
ID19574A (id) Lingkar-lingkar aneka beranggota-5 yang mempunyai substitusi bifenilsulfonil, proses pembuatannya penggunaannya sebagai obat atau diagnosa dan obat yang terdiri dari zat-zat itu
SE9700885D0 (sv) New pharmaceutical formulation
WO2005007137A8 (de) Ambroxolhaltige tabletten
HUP0301390A2 (hu) Valzartánt tartalmazó orális gyógyászati készítmény
DE69815856D1 (de) Cefadroxilmonohydrat tablettenformulierung
HUP9801414A2 (hu) Nátrium-alginátot és kálium-bikarbonátot tartalmazó folyékony vizes gyógyszerkészítmények
MY136059A (en) Swallow tablet comprising paracetamol
HUP0102125A2 (hu) Levotiroxin-nátriumot tartalmazó gyógyszerészeti készítmény
ITRM930291A0 (it) Procedimento per la preparazione di biopolimeri iodurati con attivita'disinfettante e cicatrizzante, e biopolimeri iodurati cosi' ottenuti.
HUP0001104A2 (hu) Ibuprofent és domperidont tartalmazó készítmények migrén kezelésére
HUP9902458A2 (hu) Nyújtott hatóanyag-leadású, mizolasztintartalmú gyógyszerkészítmények
HUP9701112A2 (hu) Antiflatulenst tartalmazó töltőanyag lágy zselatin kapszula gyógyszeradagolási formához
EP1383375A4 (en) PHARMACEUTICAL STRUCTURE OF CONTRIBUTION NOW IN THE STOMACH
HUP0001342A2 (hu) Gyógyszerkészítmény a terméketlenség kezelésére és a termékenység fokozására

Legal Events

Date Code Title Description
GB9A Succession in title

Owner name: GLAXOSMITHKLINE CONSUMER HEALTHCARE INVESTMENT, IE

Free format text: FORMER OWNER(S): SMITHKLINE BEECHAM P.L.C., GB